Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain
- PMID: 17074629
- DOI: 10.1016/j.jpain.2006.09.012
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain
Comment on
-
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.J Pain. 2006 Jun;7(6):399-407. doi: 10.1016/j.jpain.2006.01.443. J Pain. 2006. PMID: 16750796 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
